High Intensity Aerobic Interval Training Versus Continuous Training in Heart Failure Patients.
NCT ID: NCT05948371
Last Updated: 2024-03-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
26 participants
INTERVENTIONAL
2023-09-01
2023-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparative Effects of Aerobic Exercises, Resistance Training and Combined Training on Heart Failure Patients
NCT04937231
Different Intensities of Continuous Aerobic Exercises in Cardiac Rehab Phase 2
NCT04624412
Eccentric Resistance Training Among Individuals With Chronic Heart Failure
NCT06032780
Aerobic Interval Training v/s Resistance Interval Training On Ejection Fraction In Stable Post MI Patients
NCT03708484
Comparitive Effects of Elliptical Training vs Resistance Training on Cardiopulmonary Parameters in Post CABG Patients
NCT06656117
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
High Intensity interval Training
High Intensity interval Training
High Intensity interval Training
* Frequency: 3-5 day per week
* Intensity: 60 to 80% of HRR. If atrial fibrillation present use RPE of 11-14 on a 6-20 scale.
* Time: total 30 mint time.6 mint exercise with high intensity and 2 mints of low intensity for active recovery until 30 mints complete.
Type: walking and static cycling. Walking
* Frequency 3 -5 days per week Intensity : use RPE of 11-14.
* Time:30 mint total. 6 mint walk with high intensity and 2 mint walk with low intensity until 30mints completed.
Continuous Aerobic training
Continuous Aerobic training
Continuous Aerobic training
* Frequency : 3-5 days per week.
* Intensity:40-70% of HHR.
* Time : initial 5-10 then 10-15 until 30mints without rest interval
* Type : walking and static cycling.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
High Intensity interval Training
High Intensity interval Training
* Frequency: 3-5 day per week
* Intensity: 60 to 80% of HRR. If atrial fibrillation present use RPE of 11-14 on a 6-20 scale.
* Time: total 30 mint time.6 mint exercise with high intensity and 2 mints of low intensity for active recovery until 30 mints complete.
Type: walking and static cycling. Walking
* Frequency 3 -5 days per week Intensity : use RPE of 11-14.
* Time:30 mint total. 6 mint walk with high intensity and 2 mint walk with low intensity until 30mints completed.
Continuous Aerobic training
Continuous Aerobic training
* Frequency : 3-5 days per week.
* Intensity:40-70% of HHR.
* Time : initial 5-10 then 10-15 until 30mints without rest interval
* Type : walking and static cycling.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients who can perform 6 MWT.
* According to classification of American heart association, class 1 heart failure patients are included.
Exclusion Criteria
* Patients who have use pacemaker.
* Patient who have recent acute myocardial infraction or revascularization less than 3 months.
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Riphah International University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Muhammad Iqbal Tariq, PhD*
Role: PRINCIPAL_INVESTIGATOR
Riphah International University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Railway General Hospital
Rawalpindi, Punjab Province, Pakistan
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
REC/01653 Hafiza Misbah Inayat
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.